The genetic-testing company, which collected DNA data from users, is for sale in bankruptcy court. Now, 27 states and the ...

States sue to halt Regeneron's 23andMe acquisition, citing privacy concerns over user DNA data, as a court-ordered report on ...

New York and 27 other states sued bankrupt genetic testing company 23andMe to block the sale of 15 million customers' ...

The DNA of 15 million people was sold after 23andMe filed for bankruptcy and was acquired by pharmaceutical giant Regeneron. Concerns about the use of this genetic data have prompted New York Attorney ...

Twenty-seven states, including Illinois and Wisconsin, and the District of Columbia on Monday filed a lawsuit in bankruptcy ...

WilmerHale said it’s representing the law professor tapped to make privacy-related recommendations about the sale of ...

The future of the genetic data owned by 23andMe is uncertain as the company undergoes a court-supervised sale.

Dozens of states, including New York, are suing to block the sale of 23andMe personal genetic data without customer consent.

Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...

The bipartisan lawsuit was filed on Monday in St. Louis alongside a separate objection to the bankruptcy sale and is being ...

Bankrupt genetic testing company 23andMe is looking to sell its assets — most notably its customers' DNA data — for more than ...

Me’s sale to Regeneron is not yet a done deal. The privacy ombudsman is scheduled to report on the privacy aspects of the ...